Igene Biotechnology, Inc. (IGNE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
ANSYS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2001 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '10 Sep 30, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 2001 - 2005 |
Cash & Equivalents | 0.27 | 1.3 | 1.49 | 1.03 | 0.02 | 0.12 | Upgrade |
Cash & Short-Term Investments | 0.27 | 1.3 | 1.49 | 1.03 | 0.02 | 0.12 | Upgrade |
Cash Growth | -89.74% | -12.96% | 44.98% | 4611.05% | -81.81% | -41.37% | Upgrade |
Accounts Receivable | 0 | 0 | 1.05 | 2.72 | - | - | Upgrade |
Other Receivables | 2.17 | 2.32 | - | - | - | 0.02 | Upgrade |
Receivables | 2.17 | 2.32 | 1.05 | 2.72 | - | 0.02 | Upgrade |
Inventory | - | - | 2.4 | 8.06 | - | - | Upgrade |
Prepaid Expenses | 0 | 0.04 | 0.02 | 0.04 | 0.01 | 0.02 | Upgrade |
Total Current Assets | 2.44 | 3.66 | 4.96 | 11.84 | 0.04 | 0.16 | Upgrade |
Property, Plant & Equipment | 0.75 | 0.85 | 0.83 | 0.01 | 0.03 | 0.05 | Upgrade |
Other Intangible Assets | 0.22 | 0.24 | 0.27 | 0.54 | - | - | Upgrade |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.71 | 0.01 | 0.01 | Upgrade |
Total Assets | 3.41 | 4.76 | 6.07 | 13.1 | 0.07 | 0.23 | Upgrade |
Accounts Payable | 0.52 | 0.47 | 2.85 | 7.9 | 0.21 | 0.1 | Upgrade |
Accrued Expenses | - | - | - | - | 0.05 | 0.01 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 0.71 | 0.71 | Upgrade |
Other Current Liabilities | 1.61 | 1.09 | - | - | - | - | Upgrade |
Total Current Liabilities | 2.13 | 1.56 | 2.85 | 7.9 | 0.96 | 0.82 | Upgrade |
Long-Term Debt | 0.36 | 0.36 | 0.35 | 7.89 | 5.72 | 9.66 | Upgrade |
Other Long-Term Liabilities | 5.36 | 5.34 | 5.31 | 11.44 | 5.66 | 4.9 | Upgrade |
Total Liabilities | 7.85 | 7.26 | 8.51 | 27.23 | 12.34 | 15.37 | Upgrade |
Common Stock | 15.65 | 15.6 | 15.19 | 1.1 | 1.09 | 1.07 | Upgrade |
Additional Paid-In Capital | 34.47 | 34.47 | 34.89 | 33.28 | 33.27 | 25.45 | Upgrade |
Retained Earnings | -54.86 | -52.87 | -52.73 | -48.74 | -46.84 | -42.02 | Upgrade |
Comprehensive Income & Other | 0.05 | 0.06 | -0.02 | - | - | - | Upgrade |
Total Common Equity | -4.69 | -2.74 | -2.68 | -14.36 | -12.48 | -15.5 | Upgrade |
Shareholders' Equity | -4.44 | -2.5 | -2.44 | -14.13 | -12.26 | -15.14 | Upgrade |
Total Liabilities & Equity | 3.41 | 4.76 | 6.07 | 13.1 | 0.07 | 0.23 | Upgrade |
Total Debt | 0.36 | 0.36 | 0.35 | 7.89 | 6.42 | 10.36 | Upgrade |
Net Cash (Debt) | -0.09 | 0.93 | 1.13 | -6.86 | -6.4 | -10.24 | Upgrade |
Net Cash Growth | - | -17.90% | - | - | - | - | Upgrade |
Net Cash Per Share | -0.00 | 0.00 | 0.01 | -0.06 | -0.06 | -0.10 | Upgrade |
Filing Date Shares Outstanding | 1,565 | 1,560 | 1,519 | 110.34 | 109.34 | 107.46 | Upgrade |
Total Common Shares Outstanding | 1,565 | 1,560 | 1,519 | 110.34 | 109.34 | 107.46 | Upgrade |
Working Capital | 0.31 | 2.1 | 2.11 | 3.94 | -0.93 | -0.66 | Upgrade |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.13 | -0.11 | -0.14 | Upgrade |
Tangible Book Value | -4.9 | -2.98 | -2.95 | -14.9 | -12.48 | -15.5 | Upgrade |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.14 | -0.11 | -0.14 | Upgrade |
Machinery | - | 1.36 | 1.19 | 0.26 | 0.31 | 0.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.